Françoise Heymans

1.2k total citations
54 papers, 1.0k citations indexed

About

Françoise Heymans is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Françoise Heymans has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Organic Chemistry and 9 papers in Pharmacology. Recurrent topics in Françoise Heymans's work include HIV Research and Treatment (6 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Receptor Mechanisms and Signaling (6 papers). Françoise Heymans is often cited by papers focused on HIV Research and Treatment (6 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Receptor Mechanisms and Signaling (6 papers). Françoise Heymans collaborates with scholars based in France, Belgium and China. Françoise Heymans's co-authors include Jacques Benveniste, Jean‐Jacques Godfroid, Jean Michel Mencia‐Huerta, Ewa Ninio, Élie Michel, Catherine Redeuilh, Eliane Coëffier, Chang‐Zhi Dong, Martine Tencé and Georges Dive and has published in prestigious journals such as PLoS ONE, Biochemical Journal and FEBS Letters.

In The Last Decade

Françoise Heymans

54 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Françoise Heymans France 19 467 219 194 156 108 54 1.0k
Timothy W. Harper United States 17 345 0.7× 192 0.9× 177 0.9× 174 1.1× 102 0.9× 30 1.0k
Bruce J. Auerbach United States 21 480 1.0× 142 0.6× 92 0.5× 153 1.0× 112 1.0× 40 1.4k
Jean‐Jacques Godfroid France 15 323 0.7× 298 1.4× 97 0.5× 83 0.5× 60 0.6× 33 797
Hisashi Shinkai Japan 14 573 1.2× 291 1.3× 217 1.1× 95 0.6× 35 0.3× 27 1.6k
Yasuteru Iijima Japan 19 465 1.0× 328 1.5× 243 1.3× 138 0.9× 48 0.4× 39 994
John P. Umland United States 14 509 1.1× 144 0.7× 439 2.3× 94 0.6× 143 1.3× 17 1.2k
Dennis Dean United States 25 614 1.3× 571 2.6× 171 0.9× 88 0.6× 50 0.5× 66 2.0k
Victor Kenyon United States 16 451 1.0× 248 1.1× 271 1.4× 71 0.5× 68 0.6× 26 1.0k
Shinji Terao Japan 21 461 1.0× 324 1.5× 328 1.7× 342 2.2× 91 0.8× 45 1.5k
James R. Tata United States 21 637 1.4× 606 2.8× 133 0.7× 164 1.1× 47 0.4× 62 1.7k

Countries citing papers authored by Françoise Heymans

Since Specialization
Citations

This map shows the geographic impact of Françoise Heymans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Heymans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Heymans more than expected).

Fields of papers citing papers by Françoise Heymans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Heymans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Heymans. The network helps show where Françoise Heymans may publish in the future.

Co-authorship network of co-authors of Françoise Heymans

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Heymans. A scholar is included among the top collaborators of Françoise Heymans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Heymans. Françoise Heymans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Chang‐Zhi, L. Tsagris, François Rannou, et al.. (2010). Design of Group IIA Secreted/Synovial Phospholipase A2 Inhibitors: An Oxadiazolone Derivative Suppresses Chondrocyte Prostaglandin E2 Secretion. PLoS ONE. 5(6). e10914–e10914. 3 indexed citations
2.
3.
Hu, Jin, Wei Zhou, Yong‐Yao Cui, et al.. (2009). Protection of PMS777, a New AChE Inhibitor with PAF Antagonism, Against Amyloid-β-Induced Neuronal Apoptosis and Neuroinflammation. Cellular and Molecular Neurobiology. 29(4). 589–595. 19 indexed citations
4.
5.
6.
Huang, Hong, Xiaoling Gao, France Massicot, et al.. (2006). Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity. The International Journal of Neuropsychopharmacology. 10(1). 21–21. 29 indexed citations
7.
Dong, Chang‐Zhi, Mohamed Touaibia, Catherine Redeuilh, et al.. (2005). Inhibition of secretory phospholipase A2. 2-Synthesis and structure–activity relationship studies of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one (PMS1062) derivatives specific for group II enzyme. Bioorganic & Medicinal Chemistry. 13(6). 1989–2007. 25 indexed citations
8.
Serradji, Nawal, Marc Martín, Salvatore Cisternino, et al.. (2004). Structure−Activity Relationships in Platelet-Activating Factor. 12. Synthesis and Biological Evaluation of Platelet-Activating Factor Antagonists with Anti-HIV-1 Activity. Journal of Medicinal Chemistry. 47(25). 6410–6419. 11 indexed citations
9.
Martín, Marc, Nawal Serradji, Gwenaëlle Le Pavec, et al.. (2000). PMS-601, a New Platelet-Activating Factor Receptor Antagonist That Inhibits Human Immunodeficiency Virus Replication and Potentiates Zidovudine Activity in Macrophages. Antimicrobial Agents and Chemotherapy. 44(11). 3150–3154. 19 indexed citations
10.
Serradji, Nawal, Marc Martín, Nathalie Dereuddre‐Bosquet, et al.. (2000). Structure−Activity Relationships in Platelet-Activating Factor (PAF). 10. From PAF Antagonism to Inhibition of HIV-1 Replication. Journal of Medicinal Chemistry. 43(11). 2149–2154. 27 indexed citations
11.
Massicot, France, Aazdine Lamouri, Clémence Martin, et al.. (1997). Preventive effects of two PAF-antagonists, PMS 536 and PMS 549, on cyclosporin-induced LLC-PK 1 oxidative injury. PubMed. 15(2). 203–214. 10 indexed citations
12.
13.
Heymans, Françoise, et al.. (1994). Design and modeling of new PAF antagonists - 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-substituted carbonyloxymethyl piperazines. Open Repository and Bibliography (University of Liège). 10. 2 indexed citations
14.
15.
Favre, Edith, Françoise Heymans, Catherine Redeuilh, et al.. (1992). Structure-activity relationships in platelet-activating factor (PAF antagonists). 6. Synthesis and in vitro antagonistic activities of 2-substituted 5-oxotetrahydrofurans.. PubMed. 5(1). 23–40. 4 indexed citations
16.
Lamouri, Aazdine, et al.. (1991). New hypothesis on the conformation of the PAF-receptor from studies on the geometry of selected platelet-activating factor-antagonists.. PubMed. 4(3). 343–6. 9 indexed citations
17.
Heymans, Françoise, et al.. (1988). Chemistry of PAF antagonists.. PubMed. 22. 25–34. 2 indexed citations
18.
Godfroid, Jean‐Jacques, et al.. (1986). Synthesis of ether phospholipids. Pharmacological Research Communications. 18. 1–10. 3 indexed citations
19.
Ninio, Ewa, Jean Michel Mencia‐Huerta, Françoise Heymans, & Jacques Benveniste. (1982). Biosynthesis of platelet-activating factor. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 710(1). 23–31. 150 indexed citations
20.
Godfroid, Jean‐Jacques, et al.. (1980). Platelet activating factor (PAF‐acether): total synthesis of 1‐O‐octadecyl 2‐O‐acetyl sn‐glycero‐3‐phosphoryl choline. FEBS Letters. 116(2). 161–164. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy W. Harper Breakdown of academic impact, for papers by Bruce J. Auerbach Breakdown of academic impact, for papers by Jean‐Jacques Godfroid Breakdown of academic impact, for papers by Hisashi Shinkai Breakdown of academic impact, for papers by Yasuteru Iijima Breakdown of academic impact, for papers by John P. Umland Breakdown of academic impact, for papers by Dennis Dean Breakdown of academic impact, for papers by Victor Kenyon Breakdown of academic impact, for papers by Shinji Terao Breakdown of academic impact, for papers by James R. Tata
Rankless by CCL
2026